AnalystsChase KnickerbockerChase Knickerbocker's Stock Forecasts
AnalystsChase Knickerbocker
Analyst Ranking
Top 49%
#2229 out of 4554 analysts
Average Return
+0.35%
Win Rate
64%7 out of 11
Risk vs Reward
Poor
Good
Chase Knickerbocker's 5 best and worst ratings
| Name / Ticker | Gain/Loss | Entry Price | Exit Price | Period | Rating |
|---|---|---|---|---|---|
Xtant Medical Holdings IncXTNT | +33.49% | $0.63 | $0.84 | 2023-04-25 - 2024-04-18 | Buy |
Acasti Pharma IncACST | +30.08% | $2.36 | $3.07 | 2024-02-06 - 2024-04-18 | Buy |
Fennec Pharmaceuticals IncFENC | +17.17% | $6.93 | $8.12 | 2022-08-07 - 2023-08-07 | Buy |
Phathom Pharmaceuticals IncPHAT | +14.27% | $7.15 | $8.17 | 2023-03-12 - 2024-03-12 | Buy |
Avadel Pharmaceuticals PLCAVDL | +9.93% | $15.81 | $17.38 | 2024-03-04 - 2024-04-18 | Buy |
Chase Knickerbocker Analyst Color
Get additional color on Chase Knickerbocker's coverage of popular stocks
Chase Knickerbocker's Stock Coverage
| Name / Ticker | No. Ratings | Rating | Price Target | Upside/Downside | Action | Date |
|---|---|---|---|---|---|---|
Indivior PLCINDV | 1 | Buy | $37.00 | +97.23% | Initiates Coverage On | 16 days ago |
Fennec Pharmaceuticals IncFENC | 2 | Buy | $18.00 | +88.09% | Maintains | a month ago |
Avadel Pharmaceuticals PLCAVDL | 1 | Buy | $22.00 | +26.58% | Maintains | a month ago |
Acasti Pharma IncACST | 1 | Buy | $6.00 | +95.44% | Initiates Coverage On | 2 months ago |
Ironwood Pharmaceuticals IncIRWD | 1 | Buy | $21.00 | +176.32% | Initiates Coverage On | 3 months ago |
Mimedx Group IncMDXG | 1 | Buy | $12.00 | +94.81% | Initiates Coverage On | 6 months ago |
Scpharmaceuticals IncSCPH | 1 | Buy | $20.00 | +343.46% | Initiates Coverage On | 7 months ago |
Xtant Medical Holdings IncXTNT | 2 | Buy | $1.20 | +43.37% | Maintains | 9 months ago |
Phathom Pharmaceuticals IncPHAT | 1 | Buy | $21.00 | N/A | Initiates Coverage On | a year ago |
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.